This paper presents a system for advanced verbal interactions between humans and artificial agents with the aim to learn a simple language in which words and their meaning are grounded in sensory-motor experiences of the agent, and which allows agents to interact and cooperate with humans in shared environments. The system learns grounded language models from examples with a minimum of user intervention and without feedback, and it has been used to understand and subsequently to generate appropriate natural language descriptions of real objects and to engage in verbal interactions with a human partner.

A taxonomic study into the anatomical, morphological and phytochemical differentiation of the genus Mentha L (Lamiaceae) in Bosnia & Hercegovina and Slovakia is presented. Following a population-based approach and using hierarchical cluster analyses the following basic species and hybrids corresponding to exclusive branches, i.e. groups, in the constructed hierarchies were recognized: Mentha aquatica, M. spicata, M. arvensis, M. longifolia, M. rotundifolia, M. × piperita, M. × villosa, M. × verticillata, M. × gentillis, M. × gracilis and M. pulegium. These groups were independently found by separate analyses of the sampled anatomical and morphological variation. In contrast, these anatomically and morphologically defined species exhibited a high level of phytochemical polymorphism which was largely inconsistent with the hierarchical classification. Among the analysed characters, the inflorescence type, dentation of the leaf margin, hair density, the type of capitate glandular hairs, and the main containing compound in essential oil proved most useful for the discrimination of taxa. However, most of the observed traits were not exclusive to a particular species and only the combined consideration of traits revealed coherent taxonomic groups. Basic species and hybrids are described in detail based on the anatomical, morphological and phytochemical characters used for their definition. The performed cluster analysis finally supported hypotheses on the parentage of some of the studied hybrids.

Charm procceses are usually not considered to be favorable candidates in the search for new physics. Recent disagreement between experimental and lattice QCD results on the D_s decay constant has motivated us to systematically reinvestigate role of leptoquarks in rare charm meson decays. We include constrains coming from the light meson decays.

Multiple studies have examined the age of onset of major depression, indicating it is most frequent in adolescence and young adulthood. In this context, the offspring of depressed parents have a 2 to 4 time increased risk for depression compared with children of non-depressed parents.Treatment for depression in adolescents can be divided into psychosocial, psychopharmacologic, somatic and combined psychosocial-psychopharmacologic, psychosocial-psychosomatic and psychopharmacologic-psychosomatic.Depression in the children and adolescent population has been an area of research for over 20 years. Among novel therapeutic strategies, transcranial magnetic stimulation (TMS) has demonstrated the most favorable side effect profile. Until this time there are no published suicide attempts associated with this treatment and it may offer an option that is not associated with stigma of electroconvulsive therapy (ECT) or medications. Further research may provide more access to this therapy and hope to children, adolescents with depression and their families.

The design of innovative, more effective, less toxic therapy of multiple myeloma (MM) is emerging in parallel to a better understanding of the underlying pathophysiology of this common hematologic malignancy. Thalidomide has changed the treatment paradigm of patients with MM. Its efficacy, however, has been compromised by significant side effects. IMiDs (immunodulatory compounds) are structural and functional analogs of thalidomide that were specifically designed to create new agents with enhanced immunomodulatory and anticancer properties and better tolerability profiles. In this article, we review the clinical trial development of the second-generation IMiDs, lenalidomide and pomalidomide. Both agents demonstrate potent activity and are highly effective and well tolerated treatment options for patients with MM.